Sign in

Mark Goines

Lead Independent Director at Life360
Board

About Mark Goines

Independent director of Life360, Inc. since April 2019; age 71. Former Vice Chairman of Personal Capital (2016–2020) and its Chief Marketing Officer and Chief Strategy Officer (2012–2020). Holds a B.S. and an MBA from the University of California, Berkeley. Selected for board service for executive experience and governance/finance expertise, with U.S. and ASX listed company exposure .

Past Roles

OrganizationRoleTenureCommittees/Impact
Personal Capital CorporationVice ChairmanJun 2016 – Sep 2020Executive leadership and strategic oversight
Personal Capital CorporationChief Marketing Officer; Chief Strategy OfficerJan 2012 – Sep 2020Led marketing and strategy functions

External Roles

OrganizationRoleTenureNotes
BillFloat, Inc.DirectorCurrentPrivate technology/app-building company board
Odeko, LLCDirectorCurrentPrivate technology/app-building company board
Ascend Credit, Inc.DirectorCurrentPrivate technology/app-building company board
Candex Solutions Inc.DirectorCurrentPrivate technology/app-building company board
Human Interest, Inc.DirectorCurrentPrivate technology/app-building company board
Chocolate Holdings LLCDirectorCurrentPrivate technology/app-building company board
Bloom Credit Inc.DirectorCurrentPrivate technology/app-building company board

No other public company directorships for Goines are disclosed in the proxy .

Board Governance

  • Independence: Board determined Goines is independent under Nasdaq and SEC standards; no disqualifying relationships identified .
  • Board leadership: Independent Chair (John Philip Coghlan); separation of Chair and CEO roles .
  • Attendance: Board met 14 times in FY2024; each director attended at least 85% of Board and committee meetings .
  • Committee structure: Audit, Compensation, and Nominating & Corporate Governance; charters refreshed effective June 7, 2024 .
  • Risk oversight: Committee chairs report material risk exposures to the Board; Audit oversees financial, compliance, privacy, cybersecurity risk .
  • Section 16 compliance: Company states all required insider filings were timely in 2024, except one late Form 4 for an executive (not Goines) .
CommitteeRoleFY2024 Meetings
Compensation CommitteeChair1 meeting; (pre-IPO Remuneration & Nomination Committee met 2 times)
Nominating & Corporate Governance CommitteeMember1 meeting; (pre-IPO Remuneration & Nomination Committee met 2 times)
Audit CommitteeNot a memberAudit met 6 times

Additional governance practices:

  • Hedging/pledging: Hedging prohibited for directors; pledging prohibited unless pre-approved (GC approval for employees; Board approval for directors) .
  • Clawback: Company adopted Incentive Compensation Recoupment Policy in line with SEC/Nasdaq (filed as Exhibit 97.1 to 10-K) .

Fixed Compensation

Program structure for non-employee directors (effective 2024):

PositionCash Retainer ($)Equity Retainer ($)Total ($)
Board Chair63,000 193,500 256,500
Board Member50,000 170,000 220,000
Audit Committee Chair (additional)5,000 15,000 20,000
Audit Committee Member (additional)4,000 6,000 10,000
Compensation Committee Chair (additional)5,000 7,000 12,000
Compensation Committee Member (additional)4,000 5,000 9,000
  • 2024 changes: Board increased director cash and equity retainers (e.g., Board Member cash from $35k→$50k; Board Member equity from $120k→$170k) based on consultant input .
  • 100% of director equity awards are RSUs .

Actual FY2024 compensation for Goines:

NameCash Fees ($)Stock Awards ($)Total ($)
Mark Goines55,000 176,981 231,981

Cash detail: Base $50,000 plus $5,000 for Compensation Committee Chair .

Performance Compensation

Director equity is service-based, not performance-conditioned:

  • Equity form: 100% RSUs for non-executive directors .
  • Performance metrics: None disclosed for director equity (no TSR/financial targets specified for directors) .
  • Clawback policy: Applies to certain executive incentive compensation per SEC/Nasdaq; not specified for directors’ RSUs .
ComponentTermsDisclosure
Equity TypeRSUs (100% of annual director equity) Disclosed
Performance MetricsNone for director equity grantsNone disclosed
Vesting ScheduleNot specified in proxy for director RSUsNot disclosed
Hedging/PledgingHedging prohibited; pledging restricted with approvalsDisclosed
ClawbackAdopted per SEC/Nasdaq (executive focus)Disclosed

Other Directorships & Interlocks

  • Public company boards: None disclosed for Goines .
  • Private boards: BillFloat, Odeko, Ascend Credit, Candex Solutions, Human Interest, Chocolate Holdings, Bloom Credit .
  • Related-person exposure: Board considered Hubble Network transactions; independence discussion notes immaterial interests for certain directors—but Goines is not listed among those with Hubble interests .
  • Compensation Committee interlocks: None during 2024; no Item 404 relationships for committee members .

Expertise & Qualifications

  • Skills cited: Executive Management, Leadership & Strategy; Governance/Risk Management; U.S. and ASX listed company experience; Finance/Accounting .
  • Education: B.S. and MBA, UC Berkeley .
  • Role on Board: Compensation Committee Chair; Nominating & Corporate Governance member—indicates governance and pay oversight expertise .

Equity Ownership

As of March 31, 2025:

HolderBeneficial Ownership (shares)% OutstandingBreakdown
Mark Goines128,869 <1% 1,507 shares direct • 91,809 via Goines Wong Living Trust • 34,045 options exercisable within 60 days • 1,508 RSUs vested/will vest but not issued within 60 days (admin)
Shares outstanding (context)76,418,660 As of March 31, 2025

Outstanding RSUs and options as of Dec 31, 2024 (director equity inventory):

NameRSU Awards (count)Stock Option Awards (count)
Mark Goines3,015 34,045

Pledging/Hedging: Company policy prohibits hedging; pledging requires approval—no pledging by Goines is disclosed .

Insider Trades (Form 4)

Recent transactions by Goines (chronological):

Notes: transaction types and post-transaction holdings per Form 4 data; “Indirect” indicates trust/indirect ownership as filed; awards at $0 reflect RSU grants [SEC Form 4 links above].

Governance Assessment

Strengths

  • Independent director with finance/governance expertise; chairs Compensation Committee and serves on Nominating & Corporate Governance—key levers for board effectiveness .
  • Robust governance infrastructure: independent Chair; refreshed committee charters; formal risk oversight and cybersecurity processes; clear hedging/pledging prohibitions; clawback policy in place .
  • Attendance strong (≥85% for all directors) and no Section 16(a) delinquency noted for Goines .
  • Compensation Committee interlocks: none; uses independent compensation consultant (Compensia) and meets in executive session, supporting independent decision-making .

Watch items / potential investor questions

  • Significant insider sales across 2024–2025, including sales around the U.S. IPO window and during 2025 as shares appreciated; while common for long-tenured holders, continued selling may be monitored for alignment optics. See Form 4 table for dates, sizes, and prices (SEC links).
  • Director pay increased meaningfully in 2024 (cash and equity retainers reset higher per market review). While market-aligned, changes can draw scrutiny; however, the structure remains primarily equity-based (RSUs), aligning with stockholder interests .
  • Related-party transactions with Hubble Network involved other directors/executives; Goines is not listed as having an interest, and the Board affirmed his independence after review .
  • Director stock ownership guidelines (e.g., multiple of retainer) are not disclosed in the proxy, limiting external assessment of ownership alignment policy for directors (no director-specific guideline disclosed).

Compensation context for executives (governance signals)

  • Company practices include double-trigger change-in-control provisions and rejection of option repricing/tax gross-ups; NEO pay majority at-risk; independent committee oversight—positive governance markers .
  • One-time IPO-related payments to executives disclosed (not to directors), showing transparency around exceptional awards .
  • Company paid underwriting discounts/commissions on behalf of selling securityholders (including directors) in the U.S. IPO—common but worth noting for optics ($3.9m for Board of Directors) .